Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters

被引:289
作者
Choudhuri, Supratim
Klaassen, Curtis D.
机构
[1] USDA, CFSAN, OFAS, DBGNR, College Pk, MD 20740 USA
[2] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA
关键词
P-glycoprotein; MDR; MRP; BCRP; expression; localization; SNP; function;
D O I
10.1080/10915810600746023
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The ATP-binding cassette (ABC) transporters constitute a large family of membrane proteins, which transport a variety of compounds through the membrane against a concentration gradient at the cost of ATP hydrolysis. Substrates of the ABC transporters include lipids, bile acids, xenobiotics, and peptides for antigen presentation. As they transport exogenous and endogenous compounds, they reduce the body load of potentially harmful substances. One by-product of such protective function is that they also eliminate various useful drugs from the body, causing drug resistance. This review is a brief summary of the structure, function, and expression of the important drug resistance-conferring members belonging to three subfamilies of the human ABC family; these areABCB1(MDR1/P-glycoprotein of subfamily ABCB), subfamily ABCC (MRPs), and ABCG2 (BCRP of subfamily ABCG), which are expressed in various organs. In the text, the transporter symbol that carries the subfamily name (such as ABCB1, ABCC1, etc.) is used interchangeably with the corresponding original names, such as MDR1/P-glycoprotein, MRP1, etc., respectively. Both nomenclatures are maintained in the text because both are still used in the transporter literature. This helps readers relate various names that they encounter in the literature. It now appears that P-glycoprotein, MRP1, MRP2, and BCRP can explain the phenomenon of multidrug resistance in all cell lines analyzed thus far. Also discussed are the gene structure, regulation of expression, and various polymorphisms in these genes. Because genetic polymorphism is thought to underlie interindividual differences, including their response to drugs and other xenobiotics, the importance of polymorphism in these genes is also discussed.
引用
收藏
页码:231 / 259
页数:29
相关论文
共 50 条
[21]   Lack of association between ABCB1, ABCG2, and ABCC2 genetic polymorphisms and multidrug resistance in partial epilepsy [J].
Kim, Dong Wook ;
Lee, Sang Kun ;
Chu, Kon ;
Jang, In-Jin ;
Yu, Kyung-Sang ;
Cho, Joo-Youn ;
Kim, Seon-Jeong .
EPILEPSY RESEARCH, 2009, 84 (01) :86-90
[22]   Interactions between Maraviroc and the ABCB1, ABCG2, and ABCC2 Transporters: An Important Role in Transplacental Pharmacokinetics [J].
Tupova, Lenka ;
Ceckova, Martina ;
Ambrus, Csilla ;
Sorf, Ales ;
Ptackova, Zuzana ;
Gaborik, Zsuzsanna ;
Staud, Frantisek .
DRUG METABOLISM AND DISPOSITION, 2019, 47 (09) :954-960
[23]   Regulation of BCRP (ABCG2) and P-Glycoprotein (ABCB1) by Cytokines in a Model of the Human Blood-Brain Barrier [J].
Poller, Birk ;
Drewe, Juergen ;
Kraehenbuehl, Stephan ;
Huwyler, Jorg ;
Gutmann, Heike .
CELLULAR AND MOLECULAR NEUROBIOLOGY, 2010, 30 (01) :63-70
[24]   Deciphering the functional role of clinical mutations in ABCB1, ABCC1, and ABCG2 ABC transporters in endometrial cancer [J].
Gupta, Aayushi ;
Singh, Manu Smriti ;
Singh, Bipin .
FRONTIERS IN PHARMACOLOGY, 2024, 15
[25]   P-glycoprotein (MDR1/ABCB1) and breast cancer resistance protein (BCRP/ABCG2) restrict brain accumulation of the JAK1/2 inhibitor, CYT387 [J].
Durmus, S. ;
Xu, N. ;
Sparidans, R. W. ;
Wagenaar, E. ;
Beijnen, J. H. ;
Schinkel, A. H. .
PHARMACOLOGICAL RESEARCH, 2013, 76 :9-16
[26]   Analyses of single nudleotide polymorphisms and haplotype linkage of the human ABCB1 (MDR1) gene in Korean [J].
Ryu, Ho-Cheol ;
Kwon, Hyog-Young ;
Choi, Il-Kuen ;
Rhee, Dong-Kwon .
ARCHIVES OF PHARMACAL RESEARCH, 2006, 29 (12) :1132-1139
[27]   A comprehensive study of polymorphisms in ABCB1, ABCC2 and ABCG2 and lung cancer chemotherapy response and prognosis [J].
Campa, Daniele ;
Mueller, Phillip ;
Edler, Lutz ;
Knoefel, Lena ;
Barale, Roberto ;
Heussel, Claus P. ;
Thomas, Michael ;
Canzian, Federico ;
Risch, Angela .
INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (12) :2920-2928
[28]   Epertinib counteracts multidrug resistance in cancer cells by antagonizing the drug efflux function of ABCB1 and ABCG2 [J].
Lin, Bing-Huan ;
Li, Yen-Ching ;
Murakami, Megumi ;
Wu, Yu-Shan ;
Huang, Yang-Hui ;
Hung, Tai-Ho ;
Ambudkar, Suresh. V. ;
Wu, Chung-Pu .
BIOMEDICINE & PHARMACOTHERAPY, 2024, 180
[29]   Development of imatinib and dasatinib resistance: dynamics of expression of drug transporters ABCB1, ABCC1, ABCG2, MVP, and SLC22A1 [J].
Gromicho, Marta ;
Dinis, Joana ;
Magalhaes, Marta ;
Fernandes, Alexandra R. ;
Tavares, Purificacao ;
Laires, Antonio ;
Rueff, Jose ;
Rodrigues, Antonio Sebastiao .
LEUKEMIA & LYMPHOMA, 2011, 52 (10) :1980-1990
[30]   Regulation of BCRP (ABCG2) and P-Glycoprotein (ABCB1) by Cytokines in a Model of the Human Blood–Brain Barrier [J].
Birk Poller ;
Jürgen Drewe ;
Stephan Krähenbühl ;
Jörg Huwyler ;
Heike Gutmann .
Cellular and Molecular Neurobiology, 2010, 30 :63-70